全文获取类型
收费全文 | 98702篇 |
免费 | 6470篇 |
国内免费 | 3185篇 |
专业分类
耳鼻咽喉 | 667篇 |
儿科学 | 1674篇 |
妇产科学 | 1075篇 |
基础医学 | 11905篇 |
口腔科学 | 1964篇 |
临床医学 | 9503篇 |
内科学 | 10786篇 |
皮肤病学 | 1597篇 |
神经病学 | 10374篇 |
特种医学 | 2769篇 |
外国民族医学 | 12篇 |
外科学 | 6320篇 |
综合类 | 16067篇 |
现状与发展 | 9篇 |
一般理论 | 1篇 |
预防医学 | 11310篇 |
眼科学 | 1106篇 |
药学 | 13697篇 |
109篇 | |
中国医学 | 3553篇 |
肿瘤学 | 3859篇 |
出版年
2024年 | 170篇 |
2023年 | 1266篇 |
2022年 | 1933篇 |
2021年 | 3482篇 |
2020年 | 3234篇 |
2019年 | 2567篇 |
2018年 | 2591篇 |
2017年 | 2680篇 |
2016年 | 2920篇 |
2015年 | 2920篇 |
2014年 | 5902篇 |
2013年 | 6406篇 |
2012年 | 5862篇 |
2011年 | 6554篇 |
2010年 | 5241篇 |
2009年 | 4956篇 |
2008年 | 5133篇 |
2007年 | 5085篇 |
2006年 | 4535篇 |
2005年 | 4161篇 |
2004年 | 3424篇 |
2003年 | 3147篇 |
2002年 | 2572篇 |
2001年 | 2277篇 |
2000年 | 1994篇 |
1999年 | 1763篇 |
1998年 | 1687篇 |
1997年 | 1587篇 |
1996年 | 1289篇 |
1995年 | 1271篇 |
1994年 | 1200篇 |
1993年 | 951篇 |
1992年 | 904篇 |
1991年 | 771篇 |
1990年 | 622篇 |
1989年 | 518篇 |
1988年 | 515篇 |
1987年 | 485篇 |
1986年 | 440篇 |
1985年 | 584篇 |
1984年 | 523篇 |
1983年 | 343篇 |
1982年 | 376篇 |
1981年 | 334篇 |
1980年 | 295篇 |
1979年 | 201篇 |
1978年 | 169篇 |
1977年 | 160篇 |
1976年 | 122篇 |
1974年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 453 毫秒
61.
随着我国医疗机构临床药师队伍的不断壮大,其在医疗服务中发挥着越来越重要的作用,对其工作进行绩效考核也是当今医疗领域的重要内容。以现有文献为基础,对国内外临床药师绩效考核体系进行分析,发现现有体系可分为为基于临床药师职责、基于临床药师业务流程、国外临床药师绩效考核体系三个方面;通过结合医疗机构的实际情况对现有绩效考核体系进行分析,发现存在考核指标和标准确定困难、考核难以做到实时性和延续性等问题,并针对这些问题提出清晰职责定位、重视临床药师价值体现等修改说明。 相似文献
62.
Although hepatitis E virus (HEV) is the primary cause of enterically transmitted acute hepatitis and jaundice in developing countries, locally acquired HEV infections are increasing in nonendemic countries. As such, HEV is emerging as an underdiagnosed cause of infection. This report describes three clinically variable cases of HEV infection with unusual clinical presentations. These cases highlight the fact that HEV should be considered in the differential diagnosis of patients with unexplained hepatitis (acute or chronic) with or without extrahepatic manifestations. HEV should also be considered in patients with persistently elevated liver enzymes who have not travelled to known HEV-endemic regions. Lack of knowledge among physicians and an absence of standardized diagnostic tests may result in increased morbidity and mortality from HEV infection. 相似文献
63.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
64.
65.
Andac Salman Deniz Yucelten Ozlem Akin Cakici Eda Kepenekli Kadayifci 《Pediatric dermatology》2019,36(4):514-516
Acute generalized exanthematous pustulosis (AGEP) is seen uncommonly in children and sometimes shows atypical clinical features in this population. Patch testing can be used effectively in children for the confirmation of the culprit drug in cases of multiple drug use. Here, we report a rare, pediatric case of ceftriaxone‐induced AGEP confirmed by patch testing with subsequent recurrence of the skin eruption. 相似文献
66.
67.
68.
69.
70.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217